{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:37:27Z","timestamp":1784734647439,"version":"3.55.0"},"reference-count":200,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.numecd.2021.04.014","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T02:38:42Z","timestamp":1619577522000},"page":"2210-2233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel"],"prefix":"10.1016","volume":"31","author":[{"given":"Iacopo","family":"Chiodini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Vescini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Falchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Merlotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Eller-Vainicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rendina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Salcuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gonnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranuccio","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2021.04.014_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40842-018-0060-9","article-title":"Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification","volume":"4","author":"Valderr\u00e1bano","year":"2018","journal-title":"Clin Diab Endocrinol"},{"key":"10.1016\/j.numecd.2021.04.014_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2021.04.014_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00198-015-3279-7","article-title":"Diabetes mellitus and risk of hip fractures: a meta-analysis","volume":"27","author":"Fan","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1359\/jbmr.081207","article-title":"Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications","volume":"24","author":"Yamamoto","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00264-016-3146-y","article-title":"Increased risk of vertebral fracture in patients with diabetes: a meta-analysis of cohort studies","volume":"40","author":"Wang","year":"2016","journal-title":"Int Orthop"},{"key":"10.1016\/j.numecd.2021.04.014_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/dc19-0925","article-title":"Vertebral fractures in individuals with type 2 diabetes: more than skeletal complications alone","volume":"43","author":"Koromani","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-017-0324-x","article-title":"Association of bone mineral density, bone turnover markers, and vertebral fractures with all-cause mortality in type 2 diabetes mellitus","volume":"102","author":"Miyake","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib9","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00198-019-05122-3","article-title":"The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis","volume":"30","author":"Teb\u00e9","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.numecd.2021.04.014_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","article-title":"Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus","volume":"21","author":"Saito","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bone.2015.02.019","article-title":"Biochemical bone turnover markers in diabetes mellitus \u2014 a systematic review","volume":"82","author":"Starup-Linde","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2337\/diab.44.7.775","article-title":"Bone loss and bone turnover in diabetes","volume":"44","author":"Krakauer","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2021.04.014_bib14","first-page":"105","article-title":"Bone histomorphometry in young patients with type 2 diabetes is affected by disease control and chronic complications","author":"Andrade","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00441-014-1913-x","article-title":"Effects of high glucose and high insulin concentrations on osteoblast function in\u00a0vitro","volume":"358","author":"Cunha","year":"2014","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jcb.20842","article-title":"Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways","volume":"99","author":"Botolin","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.numecd.2021.04.014_bib17","first-page":"6","article-title":"AGEs and bone ageing in diabetes mellitus","volume":"4","author":"McCarthy","year":"2013","journal-title":"J Diabetes Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jocd.2011.06.007","article-title":"Clinical risk factors for fracture in diabetes: a matched cohort analysis","volume":"14","author":"Fraser","year":"2011","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.numecd.2021.04.014_bib19","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: an emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.bone.2007.02.021","article-title":"Biphasic fracture risk in diabetes: a population-based study","volume":"40","author":"Leslie","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib21","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diacare.24.7.1198","article-title":"Blue Mountains Eye study. Diabetes and risk of fracture: the Blue Mountains Eye study","volume":"24","author":"Ivers","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib22","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc06-0440","article-title":"Prospective study\u00a0of diabetes and risk of hip fracture: the Nurses' Health Study","volume":"29","author":"Janghorbani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib23","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1359\/jbmr.080323","article-title":"Fracture risk in type 2 diabetes: update of a population-based study","volume":"23","author":"Melton","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jdiacomp.2015.05.007","article-title":"Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care","volume":"29","author":"Rathmann","year":"2015","journal-title":"Diab Compl"},{"key":"10.1016\/j.numecd.2021.04.014_bib25","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.metabol.2014.09.002","article-title":"Type 2 diabetes mellitus and fracture risk","volume":"63","author":"Dede","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2021.04.014_bib26","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/dc12-1188","article-title":"High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study","volume":"36","author":"Oei","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib27","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/dc11-2184","article-title":"Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial","volume":"35","author":"Schwartz","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib28","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","article-title":"Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study","volume":"16","author":"de Liefde","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib29","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1210\/jc.2010-0226","article-title":"High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus","volume":"95","author":"Burghardt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib30","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1007\/s00198-016-3689-1","article-title":"Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study","volume":"27","author":"Chiang","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-008-9195-5","article-title":"Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes","volume":"84","author":"Vestergaard","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S2213-8587(17)30134-1","article-title":"Bone disease in diabetes: another manifestation of microvascular disease?","volume":"5","author":"Shanbhogue","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.numecd.2021.04.014_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2265.2011.04222.x","article-title":"Diabetic peripheral neuropathy is highly associated with nontraumatic fractures in Korean patients with type 2 diabetes mellitus","volume":"77","author":"Kim","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.numecd.2021.04.014_bib34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/jdi.12034","article-title":"Ischemic heart disease is associated with vertebral fractures in patients with type 2 diabetes mellitus","volume":"4","author":"Mu\u00f1oz-Torres","year":"2013","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.numecd.2021.04.014_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00774-012-0398-5","article-title":"The prevalence and risk factors of vertebral fractures in Korean patients with type 2 diabetes","volume":"31","author":"Chung","year":"2013","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-15-0860","article-title":"Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease","volume":"174","author":"Shanbhogue","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.numecd.2021.04.014_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009686","article-title":"Associations with fracture in patients with diabetes: a nested case-control study","volume":"6","author":"Starup-Linde","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.numecd.2021.04.014_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2337\/dc06-1267","article-title":"Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications","volume":"30","author":"Chiodini","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib39","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2014-4177","article-title":"In postmenopausal female subjects with type 2 diabetes mellitus, vertebral fractures are independently associated with cortisol secretion and sensitivity","volume":"100","author":"Zhukouskaya","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12020-017-1237-1","article-title":"Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?","volume":"58","author":"Eller-Vainicher","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.numecd.2021.04.014_bib41","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archinte.165.14.1612","article-title":"Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study","volume":"165","author":"Strotmeyer","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2021.04.014_bib42","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/diacare.25.10.1749","article-title":"Older women with diabetes have a higher risk of falls: a prospective study","volume":"25","author":"Schwartz","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib43","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2337\/diacare.23.9.1272","article-title":"Diabetes and physical disability among older U.S. adults","volume":"23","author":"Gregg","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/oxfordjournals.aje.a116871","article-title":"Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults","volume":"138","author":"Malmivaara","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2021.04.014_bib45","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1463-1326.2012.01583.x","article-title":"Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes","volume":"14","author":"Johnston","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.maturitas.2017.12.011","article-title":"The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus","volume":"109","author":"Sarodnik","year":"2018","journal-title":"Maturitas"},{"key":"10.1016\/j.numecd.2021.04.014_bib47","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2337\/dc06-2537","article-title":"Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study","volume":"30","author":"Park","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib48","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/dc09-2310","article-title":"Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS)","volume":"33","author":"Kim","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/dmrr.2658","article-title":"Neuromuscular dysfunction in type 2 diabetes: underlying mechanisms and effect of resistance training","volume":"32","author":"Orlando","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"10.1016\/j.numecd.2021.04.014_bib50","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/er.2018-00126","article-title":"Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions","volume":"40","author":"Bouillon","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.numecd.2021.04.014_bib51","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","article-title":"The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis","volume":"92","author":"Pittas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082733","article-title":"Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients","volume":"8","author":"Zoppini","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.numecd.2021.04.014_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1507\/endocrj.EJ12-0269","article-title":"The association of serum 25-hydroxyvitamin D and vertebral fractures in patients with type 2 diabetes","volume":"60","author":"Kim","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.numecd.2021.04.014_bib54","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00125-014-3289-6","article-title":"Fracture risk in diabetic elderly men: the MrOS study","volume":"57","author":"Napoli","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2021.04.014_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00592-018-1101-7","article-title":"Insulin resistance and bone: a biological partnership","volume":"55","author":"Conte","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.numecd.2021.04.014_bib56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A diabetes outcome progression trial (ADOPT)","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib57","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archinternmed.2009.214","article-title":"Thiazolidinediones and fractures in men and women","volume":"169","author":"Dormuth","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2021.04.014_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2014.08.010","article-title":"Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials","volume":"68","author":"Zhu","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jbmr.3287","article-title":"Osteoporotic fractures in men (MrOS) study research group. Vertebral fracture risk in diabetic elderly men: the MrOS study","volume":"33","author":"Napoli","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib60","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00223-016-0191-x","article-title":"DXA-based measurements in diabetes: can they predict fracture risk?","volume":"100","author":"Schacter","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib61","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","volume":"305","author":"Schwartz","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.numecd.2021.04.014_bib62","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jocd.2017.06.011","article-title":"Fracture risk assessment in patients with diabetes mellitus","volume":"20","author":"Poiana","year":"2017","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.numecd.2021.04.014_bib63","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00198-014-2822-2","article-title":"Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?","volume":"25","author":"Leslie","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib64","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes","volume":"97","author":"Gennari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00198-011-1595-0","article-title":"Bone structure and turnover in type 2 diabetes mellitus","volume":"23","author":"Shu","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00592-011-0347-0","article-title":"Serum levels of bone resorption markers are decreased in patients with type 2 diabetes","volume":"50","author":"Reyes-Garcia","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.numecd.2021.04.014_bib67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","article-title":"Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes","volume":"56","author":"Ardawi","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib68","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1210\/jc.2012-1901","article-title":"Sclerostin levels associated with inhibition of the Wnt\/\u03b2-catenin signaling and reduced bone turnover in type 2 diabetes mellitus","volume":"97","author":"Gaudio","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib69","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00198-014-2988-7","article-title":"Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures","volume":"26","author":"Heilmeier","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib70","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/jc.2007-1270","article-title":"Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes","volume":"93","author":"Yamamoto","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib71","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2008-2498","article-title":"Pentosidine and increased fracture risk in older adults with type 2 diabetes","volume":"94","author":"Schwartz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib72","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.2337\/dc09-0901","article-title":"Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes","volume":"32","author":"Yamamoto","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib73","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00198-018-4532-7","article-title":"Assessment of bone quality in patients with diabetes mellitus","volume":"29","author":"Jiang","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib74","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12020-017-1278-5","article-title":"Imaging of diabetic bone","volume":"58","author":"Ponti","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.numecd.2021.04.014_bib75","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/jbmr.499","article-title":"Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density; the Manitoba Study","volume":"26","author":"Hans","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib76","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11914-017-0410-z","article-title":"The Trabecular Bone Score (TBS) complements DXA and the FRAX as a fracture risk assessment tool in routine clinical practice","volume":"15","author":"Hans","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.numecd.2021.04.014_bib77","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","article-title":"Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice","volume":"78","author":"Harvey","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib78","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib79","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12020-016-0857-1","article-title":"Assessment of trabecular bone score (TBS) in overweight\/obese men: effect of metabolic and anthropometric factors","volume":"54","author":"Romagnoli","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.numecd.2021.04.014_bib80","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00198-014-2704-7","article-title":"Moses AM Bone quality assessment in type 2 diabetes mellitus","volume":"25","author":"Dhaliwal","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib81","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1210\/jc.2014-2047","article-title":"Trabecular bone score as an indicator for skeletal deterioration in diabetes","volume":"100","author":"Kim","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00198-015-3212-0","article-title":"The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients","volume":"27","author":"Zhukouskaya","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib83","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jocd.2016.04.001","article-title":"Trabecular bone score (TBS) and TBS-adjusted fracture risk assessment tool are potential supplementary tools for the discrimination of morphometric vertebral fractures in postmenopausal women with type 2 diabetes","volume":"19","author":"Choi","year":"2016","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.numecd.2021.04.014_bib84","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00198-019-05053-z","article-title":"Association between trabecular bone score and type 2 diabetes: a quantitative update of evidence","volume":"30","author":"Ho-Pham","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11914-007-0002-4","article-title":"Extending DXA beyond bone mineral density: understanding hip structure analysis","volume":"5","author":"Beck","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.numecd.2021.04.014_bib86","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.metabol.2012.05.010","article-title":"Hip geometry in diabetic women: implications for fracture risk","volume":"61","author":"Garg","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2021.04.014_bib87","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.metabol.2013.05.004","article-title":"Evidence for impaired skeletal load adaptation among Canadian women with type 2 diabetes mellitus: insight into the BMD and bone fragility paradox","volume":"62","author":"Hamilton","year":"2013","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.numecd.2021.04.014_bib88","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jc.2011-1883","article-title":"Diabetes and femoral neck strength: findings from the hip strength across the menopausal transition study","volume":"97","author":"Ishii","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib89","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40520-016-0634-2","article-title":"Comparison of trabecular bone score and hip structural analysis with FRAX\u00ae in postmenopausal women with type 2 diabetes mellitus","volume":"29","author":"Bonaccorsi","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib90","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.rcl.2010.02.015","article-title":"High resolution imaging techniques for the assessment of osteoporosis","volume":"48","author":"Krug","year":"2010","journal-title":"Radiol Clin"},{"key":"10.1016\/j.numecd.2021.04.014_bib91","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/jbmr.111","article-title":"Bone density, geometry, microstructure, and stiffness: relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and cQCT in premenopausal women","volume":"25","author":"Liu","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib92","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00198-014-2927-7","article-title":"Defects in cortical microarchitecture among African-American women with type 2 diabetes","volume":"26","author":"Yu","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib93","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jbmr.1763","article-title":"Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures","volume":"28","author":"Patsch","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib94","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/jbmr.3057","article-title":"Type 2 diabetes mellitus is associated with better bone microarchitecture but lower bone material strength and poorer physical function in elderly women: a population-based study","volume":"32","author":"Nilsson","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib95","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00198-011-1595-0","article-title":"Bone structure and turnover in type 2 diabetes mellitus","volume":"23","author":"Shu","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib96","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1210\/jc.2016-1437","article-title":"Advanced glycation endproducts and bone material strength in type 2 diabetes","volume":"101","author":"Furst","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib97","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/acr.20602","article-title":"Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls","volume":"64","author":"Pritchard","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib98","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2214\/ajr.183.6.01831761","article-title":"Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy X-ray absorptiometry: their ratio as a new indicator of bone weakening","volume":"183","author":"Schellinger","year":"2004","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.numecd.2021.04.014_bib99","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jc.2012-3634","article-title":"Marrow fat and bone--new perspectives","volume":"98","author":"Fazeli","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jmri.20367","article-title":"Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study","volume":"22","author":"Yeung","year":"2005","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.numecd.2021.04.014_bib101","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11914-016-0336-x","article-title":"Diabetes and bone marrow adiposity","volume":"14","author":"Kim","year":"2016","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.numecd.2021.04.014_bib102","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jbmr.1950","article-title":"Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures","volume":"28","author":"Patsch","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib103","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.rcl.2010.02.013","article-title":"Quantitative ultrasound in osteoporosis and bone metabolism pathologies","volume":"48","author":"Guglielmi","year":"2010","journal-title":"Radiol Clin"},{"key":"10.1016\/j.numecd.2021.04.014_bib104","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00223-007-9082-5","article-title":"Risk factors for fractures and falls in older women with type 2 diabetes mellitus","volume":"82","author":"Patel","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib105","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/jc.2007-1760","article-title":"Differences between measurements of bone mineral densities by quantitative ultrasound and dual-energy X-ray absorptiometry in type 2 diabetic postmenopausal women","volume":"93","author":"Tao","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib106","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00774-011-0265-9","article-title":"Quantitative ultrasound and vertebral fractures in patients with type 2 diabetes","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib107","doi-asserted-by":"crossref","first-page":"4749619","DOI":"10.1155\/2017\/4749619","article-title":"Correlates of calcaneal quantitative ultrasound parameters in patients with diabetes: the study on the assessment of determinants of muscle and bone strength abnormalities in diabetes","volume":"2017","author":"Conti","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib108","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/dme.14183","article-title":"Comparison of calcaneal quantitative ultrasound and bone densitometry parameters as fracture risk predictors in type 2 diabetes mellitus","volume":"37","author":"Jwj","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.numecd.2021.04.014_bib109","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/er.2006-0029","article-title":"Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease","volume":"28","author":"Chavassieux","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.numecd.2021.04.014_bib110","first-page":"410051","article-title":"Applications of a new handheld reference point indentation instrument measuring bone material strength","volume":"7","author":"Randall","year":"2013","journal-title":"J Med Dev Trans ASME"},{"key":"10.1016\/j.numecd.2021.04.014_bib111","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In\u00a0vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib112","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib113","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dmrr.2497","article-title":"Assessment of fracture risk by the FRAX algorithm in men and women with and without type 2 diabetes mellitus: a cross-sectional study","volume":"30","author":"Carnevale","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.numecd.2021.04.014_bib114","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jbmr.2734","article-title":"A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX","volume":"31","author":"McCloskey","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib115","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jbmr.1759","article-title":"Type 2 diabetes and bone","volume":"27","author":"Leslie","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib116","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/jbmr.3538","article-title":"Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD registry","volume":"33","author":"Leslie","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib117","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1210\/jc.2008-0926","article-title":"National Osteoporosis Foundation Guide Committee. A revised clinician's guide to the prevention and treatment of osteoporosis","volume":"93","author":"Dawson-Hughes","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib118","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","article-title":"Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics","volume":"22","author":"Shuhart","year":"2019","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.numecd.2021.04.014_bib119","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.numecd.2021.04.014_bib120","first-page":"S111","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2021.04.014_bib122","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00198-015-3123-0","article-title":"Oral antidiabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review","volume":"26","author":"Palermo","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib123","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2021.04.014_bib124","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/09513590.2020.1718092","article-title":"Metformin use is associated with a lower risk of osteoporosis in adult women independent of type 2 diabetes mellitus and obesity. REDLINC IX study","volume":"36","author":"Bl\u00fcmel","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.numecd.2021.04.014_bib125","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00125-012-2668-0","article-title":"Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs","volume":"55","author":"Colhoun","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2021.04.014_bib126","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/GME.0000000000001473","article-title":"The effect of metformin on vertebral marrow fat in postmenopausal women with newly diagnosed type 2 diabetes mellitus","volume":"27","author":"Lin","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.numecd.2021.04.014_bib127","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00198-019-04948-1","article-title":"Metformin use and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"30","author":"Salari-Moghaddam","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib128","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00774-010-0160-9","article-title":"Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus","volume":"28","author":"Kanazawa","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib129","doi-asserted-by":"crossref","first-page":"107990","DOI":"10.1016\/j.diabres.2019.107990","article-title":"Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis","volume":"159","author":"Zhang","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2021.04.014_bib130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jcb.21994","article-title":"PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells","volume":"106","author":"Shockley","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.numecd.2021.04.014_bib131","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00125-015-3660-2","article-title":"The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis","volume":"58","author":"Billington","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2021.04.014_bib132","article-title":"Glycemic control with thiazolidinedione is associated with fracture of T2DM patients","volume":"10","author":"Chen","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.numecd.2021.04.014_bib133","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2146\/ajhp160319","article-title":"Fracture risk associated with common medications used in treating type 2 diabetes mellitus","volume":"74","author":"Wolverton","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.numecd.2021.04.014_bib134","first-page":"914","article-title":"IRIS trial investigators. Pioglitazone and risk for bone fracture: safety data from a randomized clinical trial","volume":"102","author":"Viscoli","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1871530318666180423121833","article-title":"Pioglitazone therapy and fractures: systematic review and meta- analysis","volume":"18","author":"Pavlova","year":"2018","journal-title":"Endocr Metab Immune Disord - Drug Targets"},{"key":"10.1016\/j.numecd.2021.04.014_bib136","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2021.04.014_bib137","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6793-11-12","article-title":"Receptors and effects of gut hormones in three osteoblastic cell lines","volume":"11","author":"Pacheco-Pantoja","year":"2011","journal-title":"BMC Physiol"},{"key":"10.1016\/j.numecd.2021.04.014_bib138","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00198-014-2845-8","article-title":"Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength","volume":"26","author":"Mieczkowska","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib139","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-014-0361-4","article-title":"Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials","volume":"48","author":"Su","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.numecd.2021.04.014_bib140","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/1753-0407.12102","article-title":"Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials","volume":"6","author":"Mabilleau","year":"2014","journal-title":"J Diabetes"},{"key":"10.1016\/j.numecd.2021.04.014_bib141","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4158\/EP15758.OR","article-title":"Comparison of the long term effects of liraglutide and glimperide monotherapy on bone mineral density in patients with type 2 diabetes","volume":"22","author":"Gilbert","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.numecd.2021.04.014_bib142","doi-asserted-by":"crossref","first-page":"e3168","DOI":"10.1002\/dmrr.3168","article-title":"Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"35","author":"Cheng","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.numecd.2021.04.014_bib143","doi-asserted-by":"crossref","first-page":"115197","DOI":"10.1016\/j.bone.2019.115197","article-title":"Bone resorption is unchanged by liraglutide in type 2 diabetes patients: a randomised controlled trial","volume":"132","author":"Hygum","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib144","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/dc07-1736","article-title":"Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib145","first-page":"1","article-title":"Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany\u2014a retrospective analysis of real-world data","volume":"29","author":"Dombrowski","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib146","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.diabres.2016.04.029","article-title":"DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes - a systematic review and meta-analysis","volume":"116","author":"Mamza","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2021.04.014_bib147","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2019.34.e224","article-title":"Effect of dipeptidyl peptidase-4 inhibitors on the risk of bone fractures in a Korean population","volume":"34","author":"Ustulin","year":"2019","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.numecd.2021.04.014_bib148","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40264-014-0213-4","article-title":"Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events","volume":"37","author":"Ptaszynska","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.numecd.2021.04.014_bib149","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/dmrr.2903","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis","volume":"33","author":"Ruanpeng","year":"2017","journal-title":"Diabetes Metab Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib150","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/dom.12742","article-title":"Lack of evidence for a harmful effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials","volume":"18","author":"Tang","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib151","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","article-title":"Possible adverse effects of SGLT2 inhibitors on bone","volume":"3","author":"Taylor","year":"2015","journal-title":"The lancet Diabetes & endocrinology"},{"key":"10.1016\/j.numecd.2021.04.014_bib152","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/ki.2013.356","article-title":"Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control","volume":"85","author":"Kohan","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib153","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib154","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"CREDENCE trial investigators. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.04.014_bib155","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3170","article-title":"Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: an updated meta-analysis","volume":"35","author":"Li","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.numecd.2021.04.014_bib156","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1083\/jcb.200204046","article-title":"Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts","volume":"159","author":"Akune","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.numecd.2021.04.014_bib157","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s002239900163","article-title":"Insulin increases histomorphometric indices of bone formation in\u00a0vivo","volume":"59","author":"Cornish","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib158","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bone.2018.04.004","article-title":"Effects of metformin, rosiglitazone and\u00a0insulin on bone metabolism in patients with type 2 diabetes","volume":"112","author":"Stage","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib159","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","article-title":"Older women with diabetes have an increased risk of fracture: prospective study","volume":"86","author":"Schwartz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib160","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00198-018-4581-y","article-title":"Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study","volume":"29","author":"Losada","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib161","first-page":"17","article-title":"Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care","volume":"9","author":"Pscherer","year":"2016","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.numecd.2021.04.014_bib162","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/obr.12885","article-title":"The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: systematic review and meta-analysis of observational studies","volume":"20","author":"Hidayat","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.numecd.2021.04.014_bib163","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/jbmr.3826","article-title":"Glycemic control and insulin treatment alter fracture risk in older men with type 2 diabetes mellitus","volume":"34","author":"Lee","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib164","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/CORR.0000000000001089","article-title":"Is switching from oral antidiabetic therapy to insulin associated with an increased fracture risk?","volume":"478","author":"Corrao","year":"2019","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib165","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/joim.12348","article-title":"Bone and the regulation of global energy balance","volume":"277","author":"Zhang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2021.04.014_bib166","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib167","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mce.2011.08.016","article-title":"Vitamin D and diabetes: its importance for beta cell and immune function","volume":"347","author":"Wolden-Kirk","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.numecd.2021.04.014_bib168","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00125-012-2544-y","article-title":"Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies","volume":"55","author":"Forouhi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2021.04.014_bib169","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jc.2017-01024","article-title":"The effect of improved serum 25-hydroxyvitamin D status on glycemic control in diabetic patients: a meta-analysis","volume":"102","author":"Mirhosseini","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib170","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/jbmr.475","article-title":"Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones","volume":"26","author":"Shah","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib171","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1007\/s12020-016-1171-7","article-title":"Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial","volume":"56","author":"Strollo","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.numecd.2021.04.014_bib172","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.27.7.1547","article-title":"Fracture intervention trial. Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial","volume":"27","author":"Keegan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.04.014_bib173","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00223-015-0071-9","article-title":"Efficacy and safety of risedronate in osteoporosis subjects with comorbid diabetes, hypertension, and\/or dyslipidemia: a post hoc analysis of phase III trials conducted in Japan","volume":"98","author":"Inoue","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib174","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/BF02877778","article-title":"Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis","volume":"24","author":"Dagdelen","year":"2007","journal-title":"Adv Ther"},{"key":"10.1016\/j.numecd.2021.04.014_bib175","first-page":"257","article-title":"Bisphosphonates-a good choice for women with type 2 diabetes and postmenopausal osteoporosis?","volume":"64","author":"Nan","year":"2016","journal-title":"FARMACIA"},{"key":"10.1016\/j.numecd.2021.04.014_bib176","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00223-010-9450-4","article-title":"Are antiresorptive drugs effective against fractures in patients with diabetes?","volume":"88","author":"Vestergaard","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib177","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/jbmr.040211","article-title":"Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study","volume":"19","author":"Johnell","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib178","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1359\/jbmr.070904","article-title":"Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial","volume":"23","author":"Ensrud","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib179","doi-asserted-by":"crossref","first-page":"115268","DOI":"10.1016\/j.bone.2020.115268","article-title":"Denosumab in postmenopausal women with osteoporosis and diabetes: subgroup analysis of FREEDOM and FREEDOM extension","volume":"134","author":"Ferrari","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bone.2016.06.017","article-title":"Teriparatide in patients with osteoporosis and type 2 diabetes","volume":"91","author":"Schwartz","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib181","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.04.014_bib182","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1359\/jbmr.080506","article-title":"EUROFORS Investigators. Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment","volume":"23","author":"Obermayer-Pietsch","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib183","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2018.07.013","article-title":"Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: integrated analysis of 4 prospective observational studies","volume":"116","author":"Langdahl","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib184","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jbmr.1784","article-title":"Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT","volume":"28","author":"Hansen","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/joim.12873","article-title":"Treating osteoporosis to prevent fractures: current concepts and future developments","volume":"285","author":"Lorentzon","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2021.04.014_bib186","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib187","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00223-016-0177-8","article-title":"Efficacy of osteoporosis therapies in diabetic patients","volume":"100","author":"Schwartz","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib188","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.numecd.2021.04.014_bib189","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1185\/030079905X61839","article-title":"Safety assessment of raloxifene over eight years in a clinical trial setting","volume":"21","author":"Martino","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.numecd.2021.04.014_bib190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nefro.2018.10.009","article-title":"Osteoporosis, bone mineral density and CKD-MBD (II): therapeutic implications","volume":"39","author":"Bover","year":"2019","journal-title":"Nefrologia"},{"key":"10.1016\/j.numecd.2021.04.014_bib191","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.2147\/CIA.S120175","article-title":"Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study","volume":"11","author":"Nishikawa","year":"2016","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.numecd.2021.04.014_bib192","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.numecd.2021.04.014_bib193","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1073\/pnas.0711119105","article-title":"Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice","volume":"105","author":"Ferron","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2021.04.014_bib194","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00223-011-9515-z","article-title":"Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate","volume":"89","author":"Vestergaard","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2021.04.014_bib195","article-title":"The use of alendronate is associated with a decreased incidence of type 2 diabetes mellitus\u2013a population-based cohort study in Taiwan","volume":"10","author":"Chan","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.numecd.2021.04.014_bib196","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/jbmr.1865","article-title":"Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2021.04.014_bib197","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nm.3084","article-title":"Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus","volume":"19","author":"Kiechl","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2021.04.014_bib198","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2991","article-title":"Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial","volume":"34","author":"Napoli","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.numecd.2021.04.014_bib199","doi-asserted-by":"crossref","first-page":"E1982","DOI":"10.1210\/jc.2011-0587","article-title":"Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study)","volume":"96","author":"Schafer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.04.014_bib200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bone.2014.07.008","article-title":"Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugs","volume":"67","author":"Mazziotti","year":"2014","journal-title":"Bone"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321001848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321001848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:16:31Z","timestamp":1760544991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475321001848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":200,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0939475321001848"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2021.04.014","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2021.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}